Innovations in future directions & emerging therapies in diabetes and endocrinology are revolutionizing the landscape of metabolic disease treatment. Research on pancreatic beta-cell regeneration, stem cell therapy, and gene editing holds potential for long-term diabetes remission. Immunomodulatory approaches aim to halt autoimmune destruction in type 1 diabetes, while artificial intelligence-driven precision medicine is refining treatment plans for type 2 diabetes. Advancements in hormonal therapies, including novel incretin-based drugs and dual-hormone insulin delivery systems, are improving glycemic control. The integration of digital health solutions, closed-loop insulin delivery, and non-invasive glucose monitoring is enhancing patient autonomy. With continuous exploration of new targets, the future of diabetes and endocrinology promises transformative solutions for personalized and preventive care.
F Buck Willis
Christian College of Medicine, Belize
Mahir Khalil Ibrahim Jallo
Thumbay University Hospital, United Arab Emirates
Anil Harrison
Midwestern University, United States
Wan Rosli Wan Ishak
Universiti Sains Malaysia, MalaysiaMahir Khalil Ibrahim Jallo
Thumbay University Hospital, United Arab Emirates
Sujith Rajan
NYU Long Island School of Medicine, United StatesWan Rosli Wan Ishak
Universiti Sains Malaysia, Malaysia
Madhu S Malo
Stapgen LLC, United States
Kaishi Yang
Albert Einstein College of Medicine, United States
Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : An intelligent hierarchical medical platform established upon high-quality datasets improves the effectiveness of glycemic management for patients across different levels of hospitals
Zhiheng Zhou, Southern Medical University
Title : Diabetes pathogenesis and prevention
Madhu S Malo, Stapgen LLC
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Differential diagnosis of diabetes in young and prevalence of LADA and LADY in young persons attending tertiary diabetes institute in Bengaluru, India
R Anil Kumar, Karnataka Institute of Endocrinology and Research
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Endocrine-specific diabetes risk modeling, glucose–insulin dynamics, and simulation-based metabolic review using the BVidAL clinical software suite
Abhishek Bansal, New Era Consultancy Services
Title : Using a multi-disciplinary clinic model to prevent diabetic foot ulcer recurrence
Kaishi Yang, Albert Einstein College of Medicine
Title : Shaping the future of diabetes care: New advancements in treatment, digital health and personalized patient care
Rupesh K Gautam, Amity Institute of Pharmacy